Listing 5.08 Weight Loss Due to Any Digestive Disorder in 2026: The BMI 17.5 Twice-in-12-Months Rule

By Anthony Albert, Benefits Research Director, Disability Exchange · Published July 12, 2026

If your GI condition is stealing weight faster than you can replace it, and your body has dropped into a range that alarms your doctors but your labs still come back in some middle zone, you already know how disability medicine treats you. Ambiguously. Weight loss from digestive disease isn't dramatic in imaging or bloodwork the way cancer is, but it's just as disabling. And SSA has one dedicated listing that captures it, if the numbers line up right.

Listing 5.08 pays disability benefits when weight loss due to any digestive disorder pushes your body mass index below 17.50 on at least two separate evaluations, at least 60 days apart, within a rolling 12-month period, despite adherence to prescribed medical treatment. That last piece is what many people miss. It's not enough to be underweight. You have to be underweight while doing what your doctor asked you to do. This post walks through the exact SSA text, the BMI math, what "adherence to prescribed treatment" really means, which digestive conditions drive most 5.08 claims, and two 2026 cases showing what wins and what loses.

Listing 5.08 in its exact SSA wording

5.08 Weight loss due to any digestive disorder (see 5.00F), despite adherence to prescribed medical treatment, with BMI of less than 17.50 calculated on at least two evaluations at least 60 days apart within a consecutive 12-month period.

And the 5.00F preamble the listing pulls in:

5.00F. How do we evaluate weight loss due to any digestive disorder under 5.08?

1. In addition to the impairments specifically mentioned in these listings, other digestive disorders, such as esophageal stricture, pancreatic insufficiency, and malabsorption, may result in significant weight loss. Impairments other than digestive disorders that cause weight loss should be evaluated under the appropriate body system for that impairment. For instance, weight loss as a result of chronic kidney disease should be evaluated under our rules for genitourinary disorders (see 6.00), and weight loss as the result of an eating disorder should be evaluated under our rules for mental disorders (see 12.00). However, if you develop a digestive disorder as the result of your other impairment, we will evaluate the acquired digestive disorder under our rules for digestive disorders. We evaluate weight loss due to any digestive disorder under 5.08 by using the body mass index (BMI).

2. BMI is the ratio of your weight to the square of your height. Calculation and interpretation of the BMI are independent of sex in adults.

a. We calculate BMI using inches and pounds, meters and kilograms, or centimeters and kilograms. We must have measurements of your weight and height without shoes for these calculations.

b. We calculate BMI using one of the following formulas:

English Formula: BMI = [Weight in Pounds / (Height in Inches x Height in Inches)] x 703

Metric Formula: BMI = Weight in Kilograms / (Height in Meters x Height in Meters)

Five elements. Weight loss. Due to a digestive disorder. Despite adherence to prescribed treatment. BMI under 17.50. Two evaluations. At least 60 days apart. Within a 12-month window.

The BMI math and the 17.50 threshold

17.50 is not an accident. The World Health Organization classifies BMI under 18.5 as underweight, under 17 as moderate thinness, and under 16 as severe thinness. SSA planted the disability threshold at 17.50, halfway between mild underweight and moderate thinness. That threshold captures patients whose weight loss is clinically severe but stops short of imminent-mortality territory.

Some worked examples using the English formula. BMI = pounds x 703 / (inches x inches).

• A 5'10" (70 inch) adult: BMI 17.50 corresponds to about 122 pounds. Anything under 122 pounds meets the BMI threshold.
• A 5'6" (66 inch) adult: BMI 17.50 corresponds to about 108 pounds. Anything under 108 pounds meets the BMI threshold.
• A 5'2" (62 inch) adult: BMI 17.50 corresponds to about 95 pounds. Anything under 95 pounds meets the BMI threshold.
• A 6'0" (72 inch) adult: BMI 17.50 corresponds to about 129 pounds.
• A 6'2" (74 inch) adult: BMI 17.50 corresponds to about 136 pounds.

SSA requires measurements taken without shoes. That's a small but non-trivial detail because clinic weights sometimes include footwear and height sometimes uses old self-reported values. Two clinical visits with your true shoeless weight and height at the same clinic or hospital tend to produce cleaner listing evidence than a self-reported home value.

The 60-day spacing and the 12-month window

You need two BMI evaluations under 17.50, spaced at least 60 days apart, both falling within a consecutive 12-month period. That 12-month period must overlap the review window in your case.

A common working scenario: your GI clinic weighs you every 8 to 12 weeks during active disease management. Pull three or four visit records over the past year. If at least two of those weights, taken without shoes, produce a BMI under 17.50 and are more than 60 days apart, you have listing evidence.

A trap: some patients cycle above and below 17.50 as they try new therapies. If your BMI dipped to 17.2 in March, rebounded to 18.1 in May on a new steroid course, and dropped again to 17.0 in August, that's still two qualifying evaluations 60-plus days apart within a 12-month window. Non-consecutive readings count. The listing does not require sustained BMI under 17.50, just two point measurements.

"Despite adherence to prescribed medical treatment"

This is where most 5.08 claims lose steam. SSA does not pay 5.08 for weight loss you could have prevented by following your doctor's plan. You need to show that your BMI is under 17.50 while you're doing what your treatment team asked.

What adherence looks like in a record:

• Documented compliance with dietary recommendations (e.g., specialized nutrition consults, oral nutritional supplements, elemental formulas)
• Adherence to disease-specific medications (immunosuppressants for IBD, pancreatic enzyme replacement for pancreatic insufficiency, PPIs and prokinetics for gastroparesis, etc.)
• Kept appointments with GI, dietician, and primary care
• Compliance with recommended tube feeding when prescribed (nasojejunal, PEG, or J-tube)
• No documented refusal of recommended therapies without medical rationale

SSA does understand that some treatments cause weight loss on their own. If your gastroparesis is being managed with continuous jejunal feeding and you still can't maintain BMI above 17.50, that supports the listing. If your Crohn's is refractory to biologics and you've completed a well-documented trial of adalimumab, infliximab, ustekinumab, or vedolizumab, that supports the listing. What breaks the claim is a record showing repeated missed appointments, refusal of recommended supplements, or unwillingness to try nutrition support that your GI team ordered.

Digestive disorders that most commonly drive listing-level weight loss

• Crohn's disease and ulcerative colitis with active inflammation, strictures, or short bowel syndrome
• Chronic pancreatitis with exocrine pancreatic insufficiency
• Pancreatic cancer or other GI malignancies (many also meet 13.00 malignant listings)
• Severe gastroparesis, often diabetic, with intractable nausea and vomiting
• Celiac disease with refractory course despite strict gluten-free diet and complications like refractory type II
• Chronic intestinal pseudo-obstruction
• Short bowel syndrome after major intestinal resection
• Achalasia with severe dysphagia despite pneumatic dilation or myotomy
• Esophageal stricture with chronic dysphagia
• Radiation enteritis after abdominal or pelvic radiotherapy
• Chronic mesenteric ischemia

Eating disorders are explicitly excluded from 5.08. If anorexia nervosa or ARFID is the primary driver, SSA evaluates under 12.13 eating disorders in the mental disorders section, not 5.08. However, if you have a secondary digestive complication from long-standing eating disorder (like refractory gastroparesis after prolonged undernutrition), that acquired digestive disorder can be evaluated under 5.00.

Working case A: Elena, 41, Miami FL, Crohn's disease with short bowel syndrome

Elena's case was clean because the BMI evaluations were well-spaced, all well under 17.50, and the adherence record was airtight. The DDS reviewer had exactly what the listing asks for.

Working case B: Kevin, 55, Denver CO, diabetic gastroparesis with adherence questions

Kevin's case shows how easy it is to lose the "adherence" battle if your medical record has any gaps. Two things saved him: a clarifying letter from the treating GI attending and a nutritionist's letter explaining why supplement intake was practically challenging in his condition. Without those, the case would likely have gone to hearing.

Cross-referencing 5.08 with other listings

Many patients who meet 5.08 also meet another listing based on their primary condition. It's worth checking:

• Crohn's or UC with obstruction, fistula, abscess, or hemorrhage may meet Listing 5.06 IBD
• Chronic liver disease with esophageal varices or hepatic encephalopathy may meet Listing 5.05
• Pancreatic malignancy may meet Listing 13.20
• Gastric or esophageal malignancy may meet Listing 13.16 or 13.17
• Chronic infections in immunocompromised patients on IBD biologics may open Listing 14.11 HIV/immune disorders

Meeting 5.08 and another listing doesn't change the outcome, but it strengthens the record and reduces the risk of a listing-not-met denial if a DDS reviewer disputes one path.

Documentation checklist before you file

• All GI clinic weight and height records from the past 12 to 18 months, shoeless
• Specialist diagnosis of the digestive disorder driving weight loss
• Treatment history including all attempted medications with responses and side effects
• Nutrition consult notes and any oral nutritional supplement or enteral feeding prescriptions
• Documentation of adherence: appointment attendance, medication refills, dietician follow-through
• Endoscopy, imaging, and lab results supporting the diagnosis
• Any hospitalization records for the underlying disorder
• Treating physician's statement addressing both severity and adherence

State pages and related listings

• Florida SSDI resources
• Colorado SSDI resources
• Texas SSDI resources
• California SSDI resources

• Listing 5.06 Inflammatory Bowel Disease
• Listing 5.05 Chronic Liver Disease
• Listing 13.20 Pancreatic Cancer

Frequently asked questions